Elanco Animal Health ELAN 深 沪
交易中 11-19 10:49:17 美东时间
21.785
+0.395
+1.85%
华盛通- 最 高22.22
- 今 开21.605
- 成交量 60.39万股
- 最 低 21.46
- 昨 收 21.39
- 总市值 108.27亿
- 52周最高 23.09
- 市盈率 静 32.05
- 换手率 0.12%
- 52周最低 8.02
- 委 比 43.02%
- 总股本 4.97亿
- 历史最高 37.61
- 量 比 0.76
- 振 幅 3.55%
- 历史最低 7.88
- 每 手 1
- 风险率 3.86%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多6 Healthcare Stocks With Strong Upward Momentum
Out with the old (tech), in with the new (healthcare). After several volatile w...
今天 01:59
Alloy Partners Launches OneHealth Studio, A Venture Studio Developed With Elanco Animal Health, To Build And Scale Companies Uniting Animal, Plant, And Human Health Innovations.
Alloy Partners today announced the launch of OneHealth Studio, a first-of-its-kind venture studio designed specifically to create and scale new companies at the convergence of animal, plant and human health in
11-13 21:05
美股大行评级 | 绩后评级扎堆！高通、ARM、礼来、Snap、Robinhood等获多家大行上调目标价；DoorDash、多邻国、Figma、飞塔信息、HubSpot等遭下调目标价
高通、ARM、礼来、Snap、Robinhood等获多家大行上调目标价；Adient、DoorDash、多邻国、Figma、飞塔信息、HubSpot、康丽数码等遭大行下调目标价
11-07 10:14
Elanco raises 2025 guidance to 6%–6.5% organic growth and $840M–$880M innovation revenue following strong Q3
Earnings Call Insights: Elanco Animal Health Incorporated (ELAN) Q3 2025 Management View Jeffrey Simmons, President and CEO, highlighted that "Elanco's strong third quarter results build on our consis...
11-06 03:42
Sarepta raised to Outperform at Mizuho on strong results
Sarepta Therapeutics (SRPT) upgraded to Outperform from Neutral at Mizuho, citing stronger confidence in the commercial uptake of Elevidys following impressive third-quarter performance. The stock is ...
11-06 02:10
Elanco Shares Poised For Upside After Another Quarter Of Outperformance
Elanco posts strong Q3 results with 10% sales growth, surpasses forecasts, and raises full-year revenue and earnings guidance for 2025.
11-05 23:07
Elanco Animal Health Sees Q4 2025 Adj EPS $0.09-$0.12 vs $0.14 Est; Sees Sales $1.085B-$1.110B vs $1.078B Est
025 Fourth Quarter(dollars in millions, except per share amounts) Guidance Revenue $1,085to$1,110Reported Net Loss $(100)to$(86)Adjusted EBITDA $168to$188Reported Loss per
11-05 19:33
Earnings Scheduled For November 5, 2025
Companies Reporting Before The Bell • Avient (NYSE:AVNT) is estimated to report...
11-05 19:12
Zoetis down after guidance cut on macro trends
Zoetis (ZTS) shares fell ~13% in the premarket on Tuesday after the animal health company, with its Q3 2025 results, cut its full-year outlook, based on macro headwinds and operational challenges, sen...
11-04 22:19
Peering Into Elanco Animal Health Inc's Recent Short Interest
Elanco Animal Health Inc's (NYSE:ELAN) short interest as a percent of float has...
10-31 22:01
